Where does Alverix, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Alverix, Inc. ranks #10,536 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Alverix, Inc. hold?

Alverix, Inc. holds 29 US utility patents granted between 2015 and 2025, spanning 7 technology areas.

What is Alverix, Inc.'s Innovation Score?

Alverix, Inc. has an Innovation Score of 34.6 out of 100 (48th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Alverix, Inc. focus on?

Alverix, Inc.'s top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 23 patents, ranking #649 of 7,863 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Alverix, Inc.'s patent grant rate increasing or decreasing?

Alverix, Inc.'s recent grant velocity is -25% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Alverix, Inc.'s patents?

Alverix, Inc.'s patents average 17.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Alverix, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Alverix, Inc.

USPTO PatentsView assignee record - 29 granted patents across 7 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Alverix ranks #10,536 of 49,997 tracked US assignees by granted-patent volume, with 29 patents across 7 technology areas.

#10,536
of 49,997 US assignees by volume: 48th percentile
by Innovation Score (34.6/100): 17.5
avg claims per patent: -25%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10536 · US Corporation #10,536 · 29 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 29 grants
UPPER-Q #10,536/49,997
PHOTO-FINISH Aesculap Implant…
CPC-NARROW G01N · 7 areas
INNOV-THIN 34.6/100
CLAIMS-RICH 17.5 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -25% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Aesculap Implant Systems, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Alverix’s 34.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.7 pts (34%) Velocity 3.0 pts (9%) Breadth 9.4 pts (27%) Claim depth 10.5 pts (30%)

Qualcomm Incorporated · highest

85
LBP Manufacturing · near

35
Alverix · this assignee

35
Glenmark Pharmaceuti… · near

35
Mission Therapeutics · near

35
Konda · near

35
3D Lighting… · lowest

7

What this shows Alverix's Innovation Score is 34.6/100 (48th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Alverix?

Each dot is one of Alverix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Alverix’s own 17.5 claims/patent is at or below the 17.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Alverix vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Alverix's grants concentrate

Alverix, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 79.3% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2018 (6 grants) versus a trough of 1 in 2017. By volume, Alverix sits between Aesculap Implant Systems, LLC and Authentic8, Inc..

Alverix's three-year grant acceleration

Alverix, Inc. shows 5 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Aesculap Implant…

29
Alegeus

29
Alenia Aermacchi…

29
Alert Innovation

29
American Orthodon…

29
Arisawa MFG

29
Audinate Holdings…

29
Authentic8

29
Alverix ◀

29

What this shows Alverix holds 29 patents at rank #10,545, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Alverix

By rank, the assignees closest to #10,545 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Alverix's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Alverix, neither rank-band nor same-CPC leaders (those blocks stay above). In G01N (Investigating OR Analysing Materials BY Determining Their…), Alverix ranks #649 of 7,863 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (35 here).

Mission Therapeutics Limited 35 Glenmark Pharmaceuticals S.A. 35 LBP Manufacturing LLC 35 Konda Technologies Inc. 35

Alverix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 48th percentile higher than 48% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Alverix, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	10.3%
2016	2	6.9%
2017	1	3.4%
2018	6	20.7%
2019	4	13.8%
2020	4	13.8%
2021	3	10.3%
2022	2	6.9%
2023	2	6.9%
2024	1	3.4%
2025partial year	1	3.4%

Which technologies does Alverix, Inc. patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 23

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 10

Y10T - Technical Subjects Covered BY Former US Classification 5

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 5

G06T - Image Data Processing OR Generation, IN General 3

G01F - Measuring Volume, Volume Flow, Mass Flow OR Liquid LEVEL; Metering BY Volume 3

H04N - Pictorial Communication, e.g. Television 2

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Alverix, Inc.'s patent record in context - here's where to go next.

Alverix, Inc.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 79.3% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #10,536 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Alverix, Inc. against Aesculap Implant Systems, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.